GLP Watchdog

Best Foundayo (Orforglipron) Providers in 2026: Ranked and Reviewed

Eli Lilly won approval for Foundayo (orforglipron) on April 1, 2026, making it the second oral GLP-1 approved for chronic weight management, after the Wegovy pill in December 2025. Commercial dispensing began on April 6, 2026. The provider list is still short and growing quickly. We track each US telehealth platform, and each pharmacy, confirmed as a Foundayo channel, verifying the pricing tiers on each provider's own website. A commercially insured patient using the Lilly Savings Card pays $25/month; cash-pay runs $149-$299/month. This page is updated weekly as further providers come online.

Lowest verified price: $149/mo36 providers compared

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

36 Foundayo (orforglipron) providers compared · independently scored against our six-factor methodology.

Quick Picks

Starting price per provider. Prices in USD per month; checked November 2026.
#ProviderScore
1LillyDirectVisit
2PreventiveMDVisit
3Walgreens Weight ManagementVisit
4Pallas HealthVisit
5Gentle HealthVisit

Compare the top providers at a glance

Every row carries a logo, our editorial rating, price, the medications prescribed, and where the seller ships. Scan down a column and the list shortens fast.

  • ★ Editor's Pick
    LillyDirect

    brand-name Zepbound or Foundayo bought from the manufacturer at a posted cash price

    From /mo
    $149
    Scales with dose
    Coverage
    50 states + DC
    Medications
    OrforglipronTirzepatide
    Visit →
  • Best Budget
    PreventiveMD

    oral orforglipron alongside the injectables

    From /mo
    $149
    Flat at every dose
    Coverage
    43 states
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Walgreens Weight Management

    brand-name Wegovy, Zepbound or Foundayo at manufacturer self-pay prices, filled at Walgreens

    From /mo
    $149+ visit fee
    Scales with dose
    Coverage
    48 states + DC
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
Show 5 more
  • Nationwide Coverage
    Pallas Health

    knowing which pharmacy fills the vial: it names Belmar Pharmacy

    From /mo
    $499
    Flat at every dose
    Coverage
    50 states + DC
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Gentle Health

    people who want dose-tiered compounded GLP-1 prices or brand GLP-1s at maker prices from one named doctor

    From /mo
    Check pricing
    Scales with dose
    Coverage
    40 states + DC
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Sesame Care

    oral orforglipron alongside the injectables

    From /mo
    $149+ care fee
    Scales with dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Bayan Health

    a priced catalog across microdose, standard-dose and tablet GLP-1 routes

    From /mo
    $269
    Flat at every dose
    Coverage
    Check intake
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
  • Tummala Health

    flat-price semaglutide at $159 a month, for buyers comfortable with a final-sale policy

    From /mo
    Check pricing
    Flat at every dose
    Coverage
    48 states + DC
    Medications
    SemaglutideTirzepatideOrforglipron
    Visit →
All 36 providers on this board, in the order this board shows them

The comparison above shows the first 8. This is the full list the filter counts refer to, in the order this board shows them; each name opens that provider’s review.

6weighted dimensions
36Foundayo (orforglipron) providers compared
Everychecked against the seller's own site
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →

Detailed Reviews

1

LillyDirect

Best for: brand-name Zepbound or Foundayo bought from the manufacturer at a posted cash price

9.1

LillyDirect is Eli Lilly's own pharmacy channel for Zepbound (tirzepatide) and the Foundayo (orforglipron) daily tablet. It fills a valid US prescription from any prescriber and can connect you with independent telehealth doctors. Self-pay Zepbound vials and KwikPens cost $299 at 2.5 mg, $399 at 5 mg and $449 at higher doses when you refill within 45 days. Self-pay Foundayo runs $149 to $299 a month by dose. Commercially insured patients with coverage can pay as little as $25 a month.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
10
Support10%
5

Pros

  • ✓Orforglipron costs $149 a month, 40% below the $248 median for brand orforglipron tablets across the sellers we compare
  • ✓Tirzepatide costs $399 a month, 69% below the $1,299 median for brand-name tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓Serves all 50 states and DC
  • ✓Names 2 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to LillyDirect
Starting from $149/moRead full review →
Visit LillyDirect →
2

PreventiveMD

Best for: oral orforglipron alongside the injectables

9.1

PreventiveMD sells compounded semaglutide and tirzepatide at one price per plan length, whatever the dose, with shipping and provider review included. Month to month, semaglutide is $119 and tirzepatide $139; the advertised $83 and $97 are 12-month plans paid up front. Brand Wegovy, Zepbound and Foundayo carry a $49 monthly membership, with the drug bought from the maker. A US-licensed provider reviews each request in writing within 24 to 48 hours, and it names its four compounding pharmacies.

Score Breakdown

Value25%
9.8
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
8.9
Support10%
7

Pros

  • ✓Semaglutide costs $119 a month, 40% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $139 a month, 48% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Orforglipron costs $149 a month, 40% below the $248 median for brand orforglipron tablets across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price stays the same as your dose goes up
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves 43 states
  • ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to PreventiveMD

Cons

  • ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $149/moRead full review →
Visit PreventiveMD →
3

Walgreens Weight Management

Best for: brand-name Wegovy, Zepbound or Foundayo at manufacturer self-pay prices, filled at Walgreens

8.7
Score breakdown, pros and cons

Walgreens Weight Management is Walgreens' online GLP-1 clinic for brand-name Wegovy, Zepbound and Foundayo, with each visit $49 and no subscription. Medication is billed separately: with a manufacturer savings card, self-pay starts at $149 a month for the Wegovy pill or Foundayo, and Zepbound pens run $299 to $449. It serves every state except Alabama and Louisiana.

Score Breakdown

Value25%
10
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
8.5
Accessibility10%
9.7
Support10%
3

Pros

  • ✓Semaglutide costs $349 a month for the medication, plus a required visit fee, 73% below the $1,299 median for brand-name semaglutide across the sellers we compare
  • ✓Tirzepatide costs $299 a month for the medication, plus a required visit fee, 77% below the $1,299 median for brand-name tirzepatide across the sellers we compare
  • ✓Orforglipron costs $149 a month for the medication, plus a required visit fee, 40% below the $248 median for brand orforglipron tablets across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication
  • ✓Serves 48 states and DC
  • ✓We found no FDA warning letters issued to Walgreens Weight Management

Cons

  • ✗Not included in the monthly price: clinician visits
  • ✗Ask which pharmacy fills the prescription before you pay, so you can check its license
Starting from $149/mo + visit feeRead full review →
Visit Walgreens Weight Management →
4

Pallas Health

Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy

8.2
Score breakdown, pros and cons

Pallas Health, run by Brentmoor, Inc., sells compounded semaglutide at $199 and tirzepatide at $299 every 4 weeks, the same at every dose, after a first month of $139 or $179. Provider care, messaging and shipping are included, and nothing is charged until a clinician prescribes. Brand Wegovy, Ozempic, Zepbound, Mounjaro, the Wegovy pill and Foundayo sell cash-pay. It names Lion MD, two physicians with NPIs and four pharmacies, and serves all 50 states plus DC.

Score Breakdown

Value25%
5
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
10
Accessibility10%
10
Support10%
7

Pros

  • ✓Semaglutide costs $199 a month, exactly the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $299 a month, close to the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price stays the same as your dose goes up
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves all 50 states and DC
  • ✓Names 4 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to Pallas Health

Cons

  • ✗Orforglipron costs $499 a month, 101% above the $248 median for brand orforglipron tablets across the sellers we compare
  • ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from $499/moRead full review →
Visit Pallas Health →
5

Gentle Health

Best for: people who want dose-tiered compounded GLP-1 prices or brand GLP-1s at maker prices from one named doctor

8.2
Score breakdown, pros and cons

Gentle Health is a Little Rock, Arkansas telehealth clinic whose one named physician prescribes compounded semaglutide and tirzepatide, or Wegovy, Zepbound and Foundayo bought from the makers. Compounded care is priced by dose tier, from $135 a month for semaglutide and $169 for tirzepatide, with medication, the doctor and refrigerated shipping included. Brand care is $28 a month plus the maker's price. It names its three pharmacies and serves 40 states and DC.

Score Breakdown

Value25%
6.6
Effectiveness25%
10
User Experience15%
8
Trust & Safety15%
9
Accessibility10%
8.4
Support10%
7

Pros

  • ✓Semaglutide costs $159 a month, 20% below the $199 median for compounded semaglutide across the sellers we compare
  • ✓Tirzepatide costs $219 a month, 19% below the $269 median for compounded tirzepatide across the sellers we compare
  • ✓Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • ✓The monthly price includes the medication, clinician visits and shipping
  • ✓Serves 40 states and DC
  • ✓Names 3 pharmacies that fill its prescriptions, which most sellers do not
  • ✓We found no FDA warning letters issued to Gentle Health

Cons

  • ✗Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Starting from —Read full review →
Visit Gentle Health →

Buying Foundayo (orforglipron): what to verify

Foundayo is the second GLP-1 pill the FDA has approved for weight loss, after the Wegovy pill, and only a small dispensing channel exists so far. It is one Lilly product. The entries here separate on access, on price, and on whether a seller is a real channel for it at all.

What to check

  • A verified channel for the real product. Specific pharmacies dispense this drug. A seller either sits inside that channel or it does not, and the distinction is checkable. Compounded orforglipron is not a legitimate product, and no listing offering one belongs in this category.
  • Whether the Lilly savings card gets applied. For commercially insured patients who qualify, the manufacturer savings card cuts the monthly cost substantially. Applying it is something a seller does or omits, and an omission usually goes unmentioned.
  • An intake a clinician actually reads. This is a prescription drug, and the review behind it is meant to be a medical one. Approval issued in seconds, with nobody reachable afterward, describes a storefront rather than a practice.

Red flags

  • Pharmacy unnamed and no LegitScript listing. Two disclosures are checkable on any compounded-GLP-1 seller: the 503A or 503B pharmacy filling the vial, and a LegitScript certification. When a site publishes neither, nothing about the contents of that vial can be confirmed from outside.
  • Instant approval with no clinician you can reach. A prescriber is supposed to read the intake and stay available once dose questions start. Approval issued automatically, with nobody reachable afterward, means the medical layer was removed rather than streamlined.
  • The advertised number is a first month. Headline figures here are usually qualified somewhere. Common forms are an opening rate that steps up with each dose increase, and a membership fee billed separately from the drug itself. Either one can double what leaves your account in month two.
  • B12, MIC, or HCG sold for weight loss. Trial evidence for weight loss sits with the GLP-1 injections and nowhere else on this aisle. A clinic that lists lipotropic, B12, or HCG shots under weight loss is selling past the record, whatever its own site says.

Every seller listed above is scored on these criteria under our six-dimension methodology, with prices re-checked against the seller’s own live site.

How we rank, and what counts as “legit”

Scoring for every provider on this page runs against our published six-factor rubric[1]: value, effectiveness, user experience, trust & safety, accessibility and support.

Each of Wegovy, Zepbound, Ozempic and Mounjaro holds its own separate FDA approval under its own NDA number[4][5]. Published Phase 3 efficacy for semaglutide at 2.4 mg (~14.9% mean weight loss across 68 weeks) comes from STEP 1[6]; those for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) come from SURMOUNT-1[7]. In 2025 the SURMOUNT-5 head-to-head set the two against each other[8].

How much of an anti-obesity medication is covered varies widely between state Medicaid programs and between commercial plans[9][10]. Under IRS Publication 502, compounded GLP-1s and brand-name ones alike are generally FSA/HSA eligible where a prescription exists[11].

Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Frequently Asked Questions

Roughly 11–12% on average at the highest dose over about 72 weeks, from once-daily oral orforglipron in Eli Lilly's Phase 3 program. Injectable tirzepatide does better (~21%); injectable semaglutide is comparable. The difference is that this one is a daily pill with no needle. FDA approval for chronic weight management came in 2026.
Yes. FDA approval for Foundayo (orforglipron) came through and commercial dispensing started in 2026. Above sits every US telehealth platform and pharmacy confirmed to dispense it, pricing attached. The channel remains small and is expanding. An eligible insured patient can lower the cost using the Lilly Savings Card.
Of the FDA-approved oral GLP-1s for weight loss it is the most effective to date, and it is a genuine once-daily pill, where oral semaglutide (Ozempic tablets/Wegovy pill) comes with strict food-and-water timing. Overall, injectable tirzepatide still produces more weight loss. So 'strongest' turns on whether a pill or an injection is what you want.
Six weighted dimensions produce the score. Value (25%) and Effectiveness (25%) carry the most, then User Experience (15%) and Trust & Safety (15%), then Accessibility (10%) and Support (10%). Behind them sits our research into pricing data, clinical evidence, user reviews and publicly available information. Those weights then combine into one overall score out of 10.
The six-dimension methodology computes each score on its own, and no commercial relationship ever moves a provider's underlying number. Every provider's full score sits on its card for you to check. Some providers do hold affiliate agreements with us, which means a commission reaches us if you click through and buy. On the lists carrying the highest commercial intent — the weight-loss injection and shot lists, the semaglutide and tirzepatide lists, the compounded and cheapest molecule lists, and the fitness-app list — affiliate partners take the top positions. Every other list runs in score order, or in price order on the cheapest lists. That placement is disclosed here, on our methodology page, and on our affiliate-disclosure page.

Glossary

The words sellers use, defined. Tap any term.

Sources & methodology — as of November 2026
  1. 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  5. 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  8. 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
  9. 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  10. 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
  11. 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.

Related Rankings